Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2019; 11(02): 144-148
DOI: 10.4103/JLP.JLP_173_18
Original Article

Microbiological profile and antibiotic susceptibility pattern of Gram-positive isolates at a tertiary care hospital

Dhruv Mamtora
Department of Microbiology, S. L. Raheja Hospital, Mumbai, Maharashtra, India
,
Sanjith Saseedharan
Department of Critical Care Medicine, S. L. Raheja Hospital, Mumbai, Maharashtra, India
,
Pallavi Bhalekar
Department of Microbiology, S. L. Raheja Hospital, Mumbai, Maharashtra, India
,
Surekha Katakdhond
Department of Microbiology, S. L. Raheja Hospital, Mumbai, Maharashtra, India
› Author Affiliations Financial support and sponsorship Nil
› Further Information
Also available at
  PDF Download Permissions and Reprints

Abstract

OBJECTIVES: Gram-positive infections such as those by Staphylococcus aureus have contributed to the disease burden by increasing the morbidity and mortality rates in India. This study aims to determine the prevalence and the antibiotic susceptibility pattern of Gram-positive pathogens at a tertiary care hospital, Mumbai, Maharashtra, India.

MATERIALS AND METHODS: This retrospective cross-sectional study was carried out from January, 2015 to December, 2017, at a tertiary care hospital in Mumbai, India. The clinical isolates were cultured, and identification was done using Vitek 2 culture system. The antibiotic susceptibility testing was done as per the Clinical Laboratory Standard Institute guidelines.

RESULTS: Out of 2132 (29%) Gram-positive isolates, S. aureus (49%) was the most common encountered pathogen, followed by Enterococcus spp. (24.5%) and coagulase-negative Staphylococcus (16%). Majority of the S. aureus were observed in patients with skin and soft-tissue infections (61.2%) followed by those suffering from respiratory (41%) and bloodstream infections (35%). Among the infections caused by S. aureus, the prevalence of methicillin resistance was 30%. While the MRSA isolates showed lower sensitivity toward co-trimoxazole (39%), clindamycin (30%), erythromycin (23%), and ciprofloxacin (10%), they showed higher susceptibility to linezolid (98%), vancomycin (98%), and teicoplanin (98%). All the isolates were found to be sensitive to daptomycin and tigecycline. While vancomycin-resistant enterococci (VRE) formed 7.5%, the linezolid-resistant enterococcus species was as high as 4.1%.

CONCLUSION: The study showed a high prevalence of MRSA and VRE, thereby emphasizing the increasing antimicrobial resistance pattern of the Gram-positive pathogens. Therefore, there is an urgent need for novel antimicrobial stewardship to restrict the ongoing resistance rate among the isolates.

Key words

Antibiotic susceptibility pattern - Gram-positive pathogen - methicillin-resistant Staphylococcus aureus - prevalence - vancomycin-resistant enterococci


Publication History

Received: 29 December 2018

Accepted: 24 February 2019

Article published online:
06 April 2020

© 2019.

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 

  • References

  • 1 Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2095-128.
  • 2 Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2197-223.
  • 3 John TJ, Dandona L, Sharma VP, Kakkar M. Continuing challenge of infectious diseases in India. Lancet 2011;377:252-69.
  • 4 Laxminarayan R, Chaudhury RR. Antibiotic resistance in India: Drivers and opportunities for action. PLoS Med 2016;13:e1001974.
  • 5 Mave V, Chandanwale A, Kagal A, Khadse S, Kadam D, Bharadwaj R, et al. High burden of antimicrobial resistance and mortality among adults and children with community-onset bacterial infections in India. J Infect Dis 2017;215:1312-20.
  • 6 Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev 2015;28:603-61.
  • 7 National Treatment Guidelines for Antimicrobial Use in Infectious Diseases. India: National centre for disease control, Directorate General of Health Services, Ministry of Health and family welfare, Government of India; 2016 (version 1). p. 2.
  • 8 Rajkumar S, Sistla S, Manoharan M, Sugumar M, Nagasundaram N, Parija SC, et al. Prevalence and genetic mechanisms of antimicrobial resistance in Staphylococcus species: A multicentre report of the Indian council of medical research antimicrobial resistance surveillance network. Indian J Med Microbiol 2017;35:53-60.
  • 9 Trivedi MB, Vegad M, Soni S. Prevalence of methicillin-resistant Staphylococcus aureus in various clinical samples in a tertiary-care hospital. Int J Med Sci Public Health 2015;4:1735-8.
  • 10 Jindal N, Malhotra R, Grover P, Singh S, Bansal R, Kaur S, et al. Methicillin resistant Staphylococcus aureus (MRSA) in Malwa region of Punjab (North-west India). Indian J Med Res 2016;143:371-2.
  • 11 Gupta R, Malik A, Rizvi M, Ahmed M, Hashmi A. Multidrug resistant Gram positive pathogens with special reference to MRSA and biofilm production in ICU patients: Recurrent challenge for clinicians. Int J Curr Microbiol App Sci 2015;1:207-12.
  • 12 Dubey D, Rath S, Sahu MC, Pattnaik L, Debata NK, Padhy RN. Surveillance of infection status of drug resistant Staphylococcus aureus in an Indian teaching hospital. Asian Pac J Trop Dis 2013;3:133-42.
  • 13 Sood S, Malhotra M, Das BK, Kapil A. Enterococcal infections & amp; antimicrobial resistance. Indian J Med Res 2008;128:111-21.
  • 14 Mathur P, Kapil A, Chandra R, Sharma P, Das B. Antimicrobial resistance in Enterococcus faecalis at a tertiary care centre of Northern India. Indian J Med Res 2003;118:25-8.
  • 15 Taneja N, Rani P, Emmanuel R, Sharma M. Significance of vancomycin resistant enterococci from urinary specimens at a tertiary care centre in Northern India. Indian J Med Res 2004;119:72-4.
  • 16 Kaur N, Chaudhary U, Aggarwal R, Bala K. Emergence of VRE and their antimicrobial sensitivity pattern in a tertiary care teaching hospital. J Med Biol Sci 2009;8:26-32.
  • 17 Praharaj I, Sujatha S, Parija SC. Phenotypic & genotypic characterization of vancomycin resistant Enterococcus isolates from clinical specimens. Indian J Med Res 2013;138:549-56.
  • 18 Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 25th ed. CLSI Supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2015.
  • 19 Clinical and Laboratory Standards Institute; Performance Standards for Antimicrobial Susceptibility Testing. 26th ed. CLSI Supplement M100S. Wayne, PA: Clinical and Laboratory Standards Institute; 2016.
  • 20 Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA 2009;302:2323-9.
  • 21 Center for Disease Dynamics, Economics & Policy. Resistance Map. Washington DC: Center for Disease Dynamics, Economics & Policy; 2015.
  • 22 Indian Network for Surveillance of Antimicrobial Resistance (INSAR) group, India. Methicillin resistant Staphylococcus aureus (MRSA) in India: Prevalence & susceptibility pattern. Indian J Med Res 2013;137:363-9.
  • 23 Saseedharan S, Sahu M, Chaddha R, Pathrose E, Bal A, Bhalekar P, et al. Epidemiology of diabetic foot infections in a reference tertiary hospital in India. Braz J Microbiol 2018;49:401-6.
  • 24 Patel AK, Patel KK, Patel KR, Shah S, Dileep P. Time trends in the epidemiology of microbial infections at a tertiary care center in west India over last 5 years. J Assoc Physicians India 2010;58 (Suppl):37-40.
  • 25 Tak V, Mathur P, Lalwani S, Misra MC. Staphylococcal blood stream infections: Epidemiology, resistance pattern and outcome at a level 1 Indian trauma care center. J Lab Physicians 2013;5:46-50.
  • 26 Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data. Lancet Infect Dis 2014;14:742-50.
  • 27 Gandra S, Tseng KK, Arora A, Bhowmik B, Robinson ML, Panigrahi B, et al. The mortality burden of multidrug-resistant pathogens in India: A retrospective observational study. Clinical Infectious Diseases 2018.
  • 28 Zhang S, Sun X, Chang W, Dai Y, Ma X. Systematic review and meta-analysis of the epidemiology of vancomycin-intermediate and heterogeneous vancomycin-intermediate Staphylococcus aureus isolates. PLoS One 2015;10:e0136082.
  • 29 Singh H, Atray M, Modi PK. Antibiotic susceptibility pattern of methicillin resistance Staphylococcus aureus in tertiary care center at southern Rajasthan. Int J Pharm Sci Res 2014;5:607-11.
  • 30 Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988;1:57-8.
  • 31 Mathur P, Chaudhary R, Dhawan B, Sharma N, Kumar L. Vancomycin-resistant Enterococcus bacteraemia in a lymphoma patient. Indian J Med Microbiol 1999;17:194-5.
  • 32 Maartens G, Benson CA. Linezolid for treating tuberculosis: A delicate balancing act. EBioMedicine 2015;2:1568-9.
  • 33 Pavani G. Linezolid resistant Staphylococcus aureus. Int J Res Med Sci 2017;2:1253-6.
  • 34 Kumar S, Bandyoapdhyay M, Chatterjee M, Mukhopadhyay P, Poddar S, Banerjee P, et al. The first linezolid-resistant Enterococcus faecium in India: High level resistance in a patient with no previous antibiotic exposure. Avicenna J Med 2014;4:13-6.